Agios Pharmaceuticals Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

23,60 EUR -0,80 EUR -3,28 %

15:46:23

STU

27,66 USD -0,75 USD -2,64 %

15:58:07

BTT

Agios Pharmaceuticals jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.1,42 Mrd. EUR

KGV2,82Div. Rendite0,00%

WKNA1W2RM

ISINUS00847X1046

SymbolAGIO

Agios Pharmaceuticals Aktien News

Sortieren:Datum Meistgelesen

26.12.25ZacksAgios Pharmaceuticals (AGIO) Surges 18.6%: Is This an Indication of Further Gains?

24.12.25MotleyFoolHere's Why Shares in Agios Pharmaceuticals Popped Today

24.12.25BenzingaDynavax Technologies, Omeros, Agios Pharmaceuticals, Nike And Other Big Stocks Moving Higher On Wednesday

WerbungAgios Pharmaceuticals-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

19.11.25MotleyFoolWhy Shares in Agios Pharmaceuticals Got Crushed Today

19.11.25BenzingaWhy Is Agios Pharmaceuticals Stock Sinking Today?

30.10.25ZacksAgios Pharmaceuticals (AGIO) Reports Q3 Loss, Beats Revenue Estimates

29.10.25BenzingaEarnings Outlook For Agios Pharmaceuticals

18.10.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

08.10.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

03.10.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

28.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

23.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

18.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

13.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

08.09.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO

31.07.25ZacksAgios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates

10.07.25ZacksAgios Pharmaceuticals (AGIO) Moves 7.7% Higher: Will This Strength Last?

01.05.25ZacksAgios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates

24.04.25ZacksAnalysts Estimate Agios Pharmaceuticals (AGIO) to Report a Decline in Earnings: What to Look Out for

13.02.25BenzingaAgios Pharmaceuticals Reveals Encouraging Data From Rare Blood Disorder Study In Younger Patients Aged Below 18 Years

13.02.25ZacksAgios Pharmaceuticals (AGIO) Reports Q4 Loss, Tops Revenue Estimates

12.04.23PR NewswireTotus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero

Agios Pharmaceuticals News

Agios Pharmaceuticals News: auf dieser Seite finden Sie alle Agios Pharmaceuticals News und Nachrichten zur Agios Pharmaceuticals Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Agios Pharmaceuticals News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Agios Pharmaceuticals News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.